Ethanol Sclerotherapy OR Laparoscopic Excision for Treating Ovarian Endometrioma?

Written By: user

IJCP Editorial Team

Published On: 28 Mar, 2024 3:46 PM | Updated On: 19 May, 2024 8:01 PM

Ethanol Sclerotherapy OR Laparoscopic Excision for Treating Ovarian Endometrioma?

A recent study that contrasted sclerotherapy and laparoscopic ovarian cystectomy regarding the recurrence rates of ovarian endometrioma, dysmenorrhea, dyspareunia, and related complications in individuals aged 25 to 38 found-

Both sclerotherapy and laparoscopic techniques are effective in reducing endometrioma-related dysmenorrhea and dyspareunia over a 12-month period.
No marked difference in the occurrence of complications and recurrence rate between these two therapies, with both being equally beneficial.
A higher rate of AMH declines after laparoscopy than after sclerotherapy; however, no significant change in serum level of AMH exists after six months of laparoscopy.

Hence, it is reasonable to conclude that sclerotherapy can be a better alternative to laparoscopic endometrioma cyst removal with added benefits like reduced cost, shorter hospital stay, and faster return to activities.

Mohtashami S, Jabarpour M, Aleyasin A, et al. Efficacy of Ethanol Sclerotherapy Versus Laparoscopic Excision in the Treatment of Ovarian Endometrioma. JOGI. 2024;74(1)

IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.